| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.3 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |